Ledger.Open graph →
SEC Form D · filed December 20, 2023

Thiogenesis Therapeutics, Corp

Offering
$252K
Sold
$252K
Exemption
Rule 506(b)
Industry
Other
Location
TORONTO, Ontario, Canada
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Patrice G. Rioux · Toronto, Ontario, CanadaExec · DirectorChristopher G. Starr · Toronto, Ontario, CanadaDirectorBrook G. Riggins · Toronto, Ontario, CanadaExec · DirectorW. Hogan G. Mullally · Toronto, Ontario, CanadaDirectorRobert Dubeau · VANCOUVER, British Columbia, CanadaExec · DirectorTryon Breytenbach · VANCOUVER, British Columbia, CanadaDirectorKenneth Cotiamco · VANCOUVER, British Columbia, CanadaDirectorSyed Mohammed · Southampton, NYDirectorKim G. Tsuchimoto · Toronto, Ontario, CanadaExec · DirectorShidan Gouran · Dover, DEDirectorSteven Snow · West Hollywood, CAExec · DirectorCharles I. Smith · Little Rock, ARDirectorEzra Serrur · Brooklyn, NYExec · DirectorHound Partners, LLC · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗